Report: Alex Rodriguez, Ryan Braun among players MLB seeks to suspend for Biogensis connection

124 Comments

Performance-enhancing drugs loomed large entering the baseball season, amid reports that dozens of players — many of them high-profile stars — could be suspended because of their reported involvement with a clinic that supplied PEDs.

That story just got bigger.

From ESPN.com investigative reporters T.J. Quinn, Pedro Gomez and Mike Fish:

Major League Baseball will seek to suspend about 20 players connected to the Miami-area clinic at the heart of an ongoing performance-enhancing drug scandal, including Alex Rodriguez and Ryan Braun, possibly within the next few weeks, “Outside the Lines” has learned. If the suspensions are upheld, the performance-enhancing drug scandal would be the largest in American sports history.

Tony Bosch, the former director of the Miami-based Biogenesis clinic, is “expected to begin meeting with officials — and naming names — within a week,” according to the ESPN.com report. A source familiar with the case confirmed to The Associated Press early Wednesday morning that Bosch has indeed agreed to talk to MLB about players linked to PEDs, and that Bosch’s information could lead to suspensions. The suspensions could be issued within two weeks, though there’s likely to be an appeals process and that may take a few months.

NBCSports.com reached both Major League Baseball and the Players’ Association on Tuesday night, but both declined to comment. Terry Fahn, Rodriguez’s publicist as of January, said to contact New York publicist Ron Berkowitz; Berkowitz declined to comment when reached by phone.

MORE: A closer look at the players facing potential suspensions

The commissioner’s office will be seeking 100-game punishments for Braun and A-Rod because they both committed two offenses — the initial doping and then lying to Major League Baseball officials. The typical punishment for first-time performance-enhancing drug offenders is a 50-game suspension.

Nationals left-hander Gio Gonzalez is not a candidate for suspension, according to Quinn, because Bosch is expected to confirm to the investigators that Gio only bought league-approved substances. Some of the other names that were found in the Biogenesis documents: Melky Cabrera, Bartolo Colon, Yasmani Grandal, Nelson Cruz, Francisco Cervelli, Jesus Montero, Jhonny Peralta, Cesar Puello, Fernando Martinez, Everth Cabrera, Fautino de los Santos and Jordan Norberto.

MORE: Why a mass suspension would be a mass fail

The Biogenesis news broke in late January, when it was reported by multiple outlets that Major League Baseball was investigating Bosch under the suspicion that his clinic represented “ground zero” for performance enhancing drugs in Florida, where a disproportionate number of major leaguers grew up, played amateur and college baseball or where they currently make their offseason homes. On January 29, the Miami New Times obtained and published a large portion of the Biogenesis clinic’s records which contained the names of several major leaguers accompanied in many cases by notations which suggested that the players were given performance enhancing drugs. The documents were not conclusive of any player’s use and, in some cases — like with Gio Gonzalez — no connection could be found between the player and any substances which are banned by Major League Baseball.

Immediately after the Miami New Times report came out all of the players involved either denied any involvement with Biogenesis whatsoever or denied that they obtained banned substances.  For example, Gonzalez claims that his father was a patient of Bosch’s. Ryan Braun claims that his attorneys used Bosch as a consultant in his successful 2012 appeal of his PED suspension. Despite the denials, the report and the documents set off a media firestorm which caused Major League Baseball to step up its investigation of the players named therein.

Report: Orioles interested in Lance Lynn

Getty Images
3 Comments

The Orioles singlehandedly kept the rumor mill churning this weekend. MLB Network’s Jon Morosi reports that the club is interested in making a play for free agent right-hander Lance Lynn, adding him to a list of potential candidates that also includes free agent righty Alex Cobb. The two are expected to command similar contracts in free agency, but Morosi notes that the Orioles may prefer Cobb based on his familiarity with the AL East.

Lynn, 30, is two years removed from Tommy John surgery on his right elbow. Despite missing the 2016 season, he bounced back with a respectable 11-8 record in 33 starts and complemented his efforts with a 3.43 ERA, 3.8 BB/9 and 7.4 SO/9 over 186 1/3 innings for the 2017 Cardinals. He lost several days with a blister on his pitching hand in early September, but managed to avoid any major injuries and can reasonably be expected to shoulder another heavy workload in 2018.

Lynn may not be the Orioles’ first choice to beef up their starting rotation, but there’s no doubt that he’ll be in high demand as one of very few viable starters on the market this winter. The veteran righty rejected his one-year, $17.4 million qualifying offer from the Cardinals on Thursday and will likely be seeking a multi-year contract, one that Derrick Goold of the St. Louis Post-Dispatch estimates around five years and $100+ million. If the Orioles are willing to bite that bullet, they’ll still need to compensate the Cardinals with their third pick in next year’s draft.